Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Extractable Volume Determination – V 2.0

Posted on By

Analytical Method Development: SOP for Extractable Volume Determination – V 2.0

Standard Operating Procedure for Extractable Volume Determination in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/271/2025
Supersedes SOP/AMD/271/2022
Page No. Page 1 of 10
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To establish a standardized and validated procedure for determining the extractable volume of sterile pharmaceutical products in containers such as ampoules, vials, syringes, and bottles, ensuring product compliance with pharmacopeial requirements.

2. Scope

This SOP applies to the

Analytical Method Development (AMD) and Quality Control (QC) departments responsible for evaluating the extractable volume from single-dose and multi-dose containers during development, validation, and routine batch release.

3. Responsibilities

  • Analytical Scientist: Conducts extractable volume tests and documents results.
  • QC Analyst: Performs sample handling, measurement, and calculation under aseptic conditions.
  • QA Executive: Reviews results and ensures compliance with USP/Ph. Eur. specifications.
See also  Analytical Method Development: Total Viable Count Method Optimization - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring validated extractable volume methods are implemented and followed per regulatory standards.

5. Procedure

5.1 Equipment and Materials

  1. Calibrated class A graduated cylinder or volumetric pipette
  2. WFI or relevant test solution
  3. Sterile syringes and needles
  4. Analytical balance (for density conversion if needed)

5.2 Test Preparation

  1. Condition the test samples to room temperature (25 ± 2°C).
  2. Use aseptic techniques when withdrawing contents.

5.3 Test Procedure

  1. Invert the container and withdraw contents completely using a sterile syringe without introducing air bubbles.
  2. Transfer the contents into a calibrated cylinder and record the volume extracted.
  3. Repeat the test for a statistically significant number of samples (n=10 for single-dose units).
  4. For multidose containers, measure volume after five repeated extractions to simulate routine use.

5.4 Acceptance Criteria

  • Single-dose containers: Not less than 90% of the labeled volume
  • Multidose containers: Not less than the labeled volume across all extractions
  • Average and individual container volumes must meet compendial expectations
See also  Analytical Method Development: SOP for LC-MS/MS Method Development in Impurity Profiling - V 2.0

5.5 Calculations

  1. Calculate % extractable volume using the formula:
    % Extractable Volume = (Measured Volume / Labeled Volume) × 100
  2. Report mean, standard deviation, and range for test units.

5.6 Method Validation Parameters

  1. Accuracy: Recovery between 98–102% with certified volume standards
  2. Precision: RSD ≤ 2% for replicate volume measurements
  3. Linearity: Demonstrated from 0.5 mL to 50 mL volumes
  4. Robustness: Evaluate influence of angle of withdrawal, syringe type, and needle gauge

6. Abbreviations

  • USP: United States Pharmacopeia
  • Ph. Eur.: European Pharmacopoeia
  • QA: Quality Assurance
  • AMD: Analytical Method Development

7. Documents

  1. Extractable Volume Test Log – Annexure-1
  2. Calibration Certificate for Glassware – Annexure-2
  3. Validation Summary Report – Annexure-3

8. References

  • USP <697>: Volume in Containers
  • Ph. Eur. 2.9.17: Extractable Volume of Parenterals
  • ICH Q2(R1): Validation of Analytical Procedures

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Amit Sharma Neelam Saxena Sunita Reddy
Designation Analytical Chemist QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Extractable Volume Test Log

Sample ID Labeled Volume (mL) Measured Volume (mL) % Extracted Status
INJ-271-01 5.0 4.8 96% Pass

Annexure-2: Calibration Certificate for Glassware

Glassware Nominal Volume Observed Volume Correction Factor Status
Graduated Cylinder 10 mL 9.98 mL -0.02 mL Pass

Annexure-3: Validation Summary Report

The extractable volume method was validated for ampoules, vials, and prefilled syringes. Accuracy and precision were within acceptable limits. Method is suitable for development and routine testing as per USP and Ph. Eur. requirements.

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Updated with linearity and robustness parameters Annual Review Sunita Reddy
20/03/2022 1.0 Initial SOP Release New SOP QA Head
See also  Analytical Method Development: SOP for Verification of Reference Standards and Working Standards - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: SOP for Creating Regulatory Compliance Checklists
Next Post: Gel Manufacturing: SOP for Production of Thermosensitive Gels – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version